Corporate Banner
Satellite Banner
Scientific Communities
Become a Member | Sign in
Home>News>This Article

Shimadzu Achieves ISO 13485 Certification for US LC-MS Facility

Published: Wednesday, September 25, 2013
Last Updated: Wednesday, October 16, 2013
Bookmark and Share
ISO 13485 is the globally recognized international quality management standard for medical equipment.

Shimadzu U.S.A Manufacturing, Inc. the U.S. manufacturing subsidiary of Shimadzu Corporation, has obtained ISO 13485 certification for the manufacture of high-performance liquid chromatographs (LC) and high-performance liquid chromatograph mass spectrometers (LCMS). 

As a result of the increased use of analytical instruments in the clinical field, the U.S. FDA (Food and Drug Administration) announced draft guidance in June 2011, requiring a clearer distinction between research equipment and IVD (in vitro diagnostic devices). This demands a strict management system to ensure the reliability and accuracy of analytical instruments when used as medical equipment. Manufacturers must first comply with the ISO 13485 standard, and thereafter follow the laws and regulations in each country and region. In other words, obtaining ISO 13485 certification is now a prerequisite when using analytical instruments as medical equipment.

In April 2013, Shimadzu Corporation expanded the scope of its ISO 13485 certification, which covered blood coagulation and automatic clinical chemistry analyzers, to include LCMS and LC instruments. Obtaining ISO 13485 certification allows SUM to manufacture and supply analytical instruments for clinical testing to the U.S. market. Shimadzu will continue to register medical devices with the FDA, and support the growing demand for LC and LCMS in the clinical testing market.

"Mass spectrometry has a growing presence in clinical research and laboratory medicine," said Shinichi Matsunaga, President of Shimadzu U.S.A. Manufacturing. "Achieving ISO 13485 certification is a major milestone for Shimadzu and a great step towards developing mass spectrometry platforms as next generation medical devices."

Shimadzu U.S.A. Manufacturing (SUM) will continue to promote activities to obtain ISO 13485 certification for other analytical instruments planned to advance into the clinical testing market. In addition, SUM will build an efficient manufacturing system as a production base to supply medical equipment devices to customers throughout the world.

Simultaneous multicomponent analysis using Shimadzu's high-speed, high-sensitivity mass spectrometers is expected to demonstrate considerable value in the clinical field. Marking this occasion of ISO 13485 certification, Shimadzu will accelerate expansion of analytical and measuring instruments into the medical field and continue to fulfill our management principle of "Realizing Our Wishes for the Well-being of both Mankind and the Earth"

Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,600+ scientific posters on ePosters
  • More Than 3,800+ scientific videos on LabTube
  • 35 community eNewsletters

Sign In

Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Agilent, Shimadzu Release GC Instrument Control for CDS
The instrument control provides customers more freedom of choice when selecting a chromatography data system.
Wednesday, August 27, 2014
Shimadzu, Indigo BioSystems Announce Partnership
The companies will leverage the power of ASCENT™ clinical solutions on ultra-fast mass spectrometry platforms.
Monday, June 16, 2014
Shimadzu Corporation, MacCoss Lab of Biological Mass Spectrometry, UW Collaborate
The companies will leverage the power of ASCENT™ clinical solutions on ultra-fast mass spectrometry platforms.
Monday, June 16, 2014
Shimadzu Registers HPLC and LCMS Instruments as Class I Medical Devices with FDA
Products are the first Shimadzu analytical instruments registered with the FDA as medical devices.
Tuesday, April 01, 2014
Shimadzu Establishes Latin American Subsidiary
Uruguayan subsidiary will strengthen company's sales and distribution whilst providing better support for customers and distributors in Central and South America.
Tuesday, November 12, 2013
Shimadzu UK Grows Sales Orders by 30%!
Company has achieved sales order growth across many products in the Shimadzu range.
Tuesday, May 07, 2013
Shimadzu UK Appoints Product Specialist for AA
Company strengthens focus on molecular and atomic spectroscopy with new specialist recruit.
Thursday, July 19, 2012
Shimadzu and The University of Texas Form Shimadzu Center for Advanced Analytical Chemistry
Located in the university’s Chemistry & Physics Building, the center contains $6 million of chromatography, mass spectrometry and spectroscopy equipment, which is the largest installation of Shimadzu analytical instrumentation in the Western Hemisphere.
Tuesday, April 10, 2012
Shimadzu Corporation Names New Director and President of Shimadzu Scientific Instruments
Shuzo Maruyama has been named president of Shimadzu Scientific Instruments (SSI)
Monday, March 12, 2012
Spectroscopy Veteran Joins Shimadzu UK to Drive UK Sales Forward
Dr Robert Keighley has appointed as new spectroscopy and TOC business manager.
Friday, September 16, 2011
Shimadzu UK Opens Evaluation Laboratory Centre to Promote Excellence in Analytical Instrumentation
New 1500m² world-class product evaluation laboratory facility at UK headquarters in Buckinghamshire.
Wednesday, July 13, 2011
Multivariate Data Analysis Solutions for FTIR Spectrophotometry
Shimadzu Scientific Instruments and CAMO Software have announced a partnership that will enable Shimadzu to expand its capabilities for FTIR spectrophotometry. Shimadzu will now provide CAMO Software’s multivariate data analysis (MVDA) software, The Unscrambler® to FTIR customers requiring chemometric analysis.
Friday, November 05, 2010
Shimadzu, Ceres Nanosciences and Nonlinear Dynamics Introduce Nanotrap™ Biomarker Discovery Platform
Shimadzu Scientific Instruments has partnered with Ceres Nanosciences and Nonlinear Dynamics to bring the future of biomarker discovery to laboratory researchers.
Tuesday, March 16, 2010
Shimadzu and Phenomenome Discoveries Announce Exclusive Collaboration
Shimadzu and PDI will develop software tools for global profiling using high mass accuracy MSn data.
Monday, July 02, 2007
Shimadzu Assumes Responsibilities for X-ray Spectrometer Business
Shimadzu transfers the X-ray spectrometer business from Kratos Analytical to SSI, which will handle sales and service of X-ray spectrometers in US, Canada, and Mexico.
Wednesday, March 07, 2007
Scientific News
Lung Repair and Regeneration Gene Discovered
New role for hedgehog gene offers better understanding of lung disease.
How Cell Growth Triggers Cell Division
Researchers in Jan Skotheim's lab have discovered a previously unknown mechanism that controls how large cells grow, an insight that could one day provide insight into attacking diseases such as cancer.
Microbe Sleuth
Tanja Bosak examines how life and the Earth evolved in tandem during their early history together.
3 Ways Viruses Have Changed Science for the Better
Viruses are really good at what they do, and we’ve been able to harness their skills to learn about – and potentially improve – human health in several ways.
Restoring Vision with Stem Cells
Age-related macular degeneration (AMRD) could be treated by transplanting photoreceptors produced by the directed differentiation of stem cells, thanks to findings published today by Professor Gilbert Bernier of the University of Montreal and its affiliated Maisonneuve-Rosemont Hospital.
The Age of Humans Controlling Microbes
Engineered bacteria could soon be used to detect environmental toxins, treat diseases, and sustainably produce chemicals and fuels.
Mixed Up Cell Transportation Key Piece of ALS and Dementia Puzzle
Researchers from the University of Toronto are one step closer to solving this incredibly complex puzzle, offering hope for treatment.
Metabolomic Platform Reveals Fundamental Flaw in Common Lab Technology
A new study led by scientists at The Scripps Research Institute (TSRI) shows that a technology used in thousands of laboratories, called gas chromatography mass spectrometry (GC-MS), fundamentally alters the samples it analyzes.
Atriva Therapeutics GmbH Develops Innovative Flu Drug
Highly effective against seasonal and pandemic influenza.
New Gene Therapy for Vision Loss From a Mitochondrial Disease
NIH-funded study shows success in targeting mitochondrial DNA in mice.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,600+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,800+ scientific videos